| Symbol |
Name |
Standardized Value |
|
USP6
|
ubiquitin specific peptidase 6
|
3.279
|
|
MYOM2
|
myomesin 2
|
3.081
|
|
CRP
|
C-reactive protein, pentraxin-related
|
2.901
|
|
CD34
|
CD34 molecule
|
2.537
|
|
CALD1
|
caldesmon 1
|
2.356
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
2.332
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
2.331
|
|
CKB
|
creatine kinase, brain
|
2.33
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
2.33
|
|
CKM
|
creatine kinase, muscle
|
2.327
|
|
ALB
|
albumin
|
2.261
|
|
TNF
|
tumor necrosis factor
|
2.168
|
|
IL6
|
interleukin 6
|
2.15
|
|
IL1B
|
interleukin 1, beta
|
2.134
|
|
SPEG
|
SPEG complex locus
|
2.126
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
2.098
|
|
FN1
|
fibronectin 1
|
2.058
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
2.011
|
|
ERVFRD-1
|
endogenous retrovirus group FRD, member 1
|
2.003
|
|
ERV3-1
|
endogenous retrovirus group 3, member 1
|
2.003
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
1.975
|
|
CD68
|
CD68 molecule
|
1.969
|
|
CD99L2
|
CD99 molecule-like 2
|
1.96
|
|
PLG
|
plasminogen
|
1.952
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
1.95
|
|
INS
|
insulin
|
1.943
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.939
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
1.937
|
|
CD4
|
CD4 molecule
|
1.936
|
|
CD99
|
CD99 molecule
|
1.931
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.919
|
|
SLC5A2
|
solute carrier family 5 (sodium/glucose cotransporter), member 2
|
1.918
|
|
F2
|
coagulation factor II (thrombin)
|
1.897
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.854
|
|
IFNG
|
interferon, gamma
|
1.851
|
|
TAC1
|
tachykinin, precursor 1
|
1.835
|
|
MB
|
myoglobin
|
1.825
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.823
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.816
|
|
IL1A
|
interleukin 1, alpha
|
1.809
|
|
IL10
|
interleukin 10
|
1.798
|
|
MYOG
|
myogenin (myogenic factor 4)
|
1.797
|
|
IL5
|
interleukin 5
|
1.797
|
|
RAB3IL1
|
RAB3A interacting protein (rabin3)-like 1
|
1.761
|
|
MPO
|
myeloperoxidase
|
1.749
|
|
CD8A
|
CD8a molecule
|
1.749
|
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
1.749
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.748
|
|
IL17A
|
interleukin 17A
|
1.716
|
|
LTF
|
lactotransferrin
|
1.7
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.692
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
1.691
|
|
TPM4
|
tropomyosin 4
|
1.68
|
|
UBAC1
|
UBA domain containing 1
|
1.677
|
|
TLR2
|
toll-like receptor 2
|
1.642
|
|
C3
|
complement component 3
|
1.642
|
|
LAPTM4A
|
lysosomal protein transmembrane 4 alpha
|
1.636
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
1.635
|
|
SETBP1
|
SET binding protein 1
|
1.631
|
|
CREB3L2
|
cAMP responsive element binding protein 3-like 2
|
1.614
|
|
COL1A1
|
collagen, type I, alpha 1
|
1.614
|
|
AZU1
|
azurocidin 1
|
1.613
|
|
CREB3L1
|
cAMP responsive element binding protein 3-like 1
|
1.611
|
|
TRIM33
|
tripartite motif containing 33
|
1.61
|
|
MUC4
|
mucin 4, cell surface associated
|
1.601
|
|
IL2
|
interleukin 2
|
1.599
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.594
|
|
IL4
|
interleukin 4
|
1.589
|
|
TLR4
|
toll-like receptor 4
|
1.572
|
|
PPP6R3
|
protein phosphatase 6, regulatory subunit 3
|
1.57
|
|
MYOD1
|
myogenic differentiation 1
|
1.569
|
|
HOXD13
|
homeobox D13
|
1.555
|
|
EWSR1
|
EWS RNA-binding protein 1
|
1.552
|
|
TBPL1
|
TBP-like 1
|
1.541
|
|
ELANE
|
elastase, neutrophil expressed
|
1.527
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
1.526
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
1.525
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
1.523
|
|
MORC3
|
MORC family CW-type zinc finger 3
|
1.509
|
|
MEFV
|
Mediterranean fever
|
1.503
|
|
IFNA1
|
interferon, alpha 1
|
1.503
|
|
TPM3
|
tropomyosin 3
|
1.499
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.497
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.491
|
|
GUK1
|
guanylate kinase 1
|
1.487
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.485
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
1.48
|
|
MME
|
membrane metallo-endopeptidase
|
1.48
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
1.476
|
|
SEC31A
|
SEC31 homolog A (S. cerevisiae)
|
1.471
|
|
PRTN3
|
proteinase 3
|
1.461
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.459
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.441
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
1.438
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.428
|
|
VIM
|
vimentin
|
1.427
|
|
KNG1
|
kininogen 1
|
1.425
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
1.418
|
|
B4GALNT2
|
beta-1,4-N-acetyl-galactosaminyl transferase 2
|
1.414
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
1.404
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
1.402
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
1.395
|
|
CAMTA1
|
calmodulin binding transcription activator 1
|
1.391
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
1.387
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
1.382
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
1.38
|
|
GCAT
|
glycine C-acetyltransferase
|
1.38
|
|
ARX
|
aristaless related homeobox
|
1.379
|
|
SUCLG2
|
succinate-CoA ligase, GDP-forming, beta subunit
|
1.379
|
|
RRBP1
|
ribosome binding protein 1
|
1.37
|
|
MDH2
|
malate dehydrogenase 2, NAD (mitochondrial)
|
1.369
|
|
PLK4
|
polo-like kinase 4
|
1.369
|
|
NUCB1
|
nucleobindin 1
|
1.367
|
|
MYD88
|
myeloid differentiation primary response 88
|
1.364
|
|
EDNRB
|
endothelin receptor type B
|
1.363
|
|
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1
|
1.362
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
1.361
|
|
ACE
|
angiotensin I converting enzyme
|
1.356
|
|
FUS
|
FUS RNA binding protein
|
1.351
|
|
LIAS
|
lipoic acid synthetase
|
1.349
|
|
VTN
|
vitronectin
|
1.347
|
|
CCNF
|
cyclin F
|
1.347
|
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)
|
1.346
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
1.343
|
|
IL13
|
interleukin 13
|
1.338
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
1.333
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.33
|
|
TLR9
|
toll-like receptor 9
|
1.328
|
|
CD274
|
CD274 molecule
|
1.321
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
1.32
|
|
IL18
|
interleukin 18
|
1.316
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
1.314
|
|
FGF7
|
fibroblast growth factor 7
|
1.313
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.309
|
|
KRT5
|
keratin 5, type II
|
1.3
|
|
ELN
|
elastin
|
1.299
|
|
PCNA
|
proliferating cell nuclear antigen
|
1.298
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.297
|
|
JAK1
|
Janus kinase 1
|
1.295
|
|
PXDN
|
peroxidasin
|
1.292
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
1.291
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.289
|
|
TP53
|
tumor protein p53
|
1.289
|
|
FBXO3
|
F-box protein 3
|
1.288
|
|
CLTC
|
clathrin, heavy chain (Hc)
|
1.287
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
1.285
|
|
PXDNL
|
peroxidasin-like
|
1.283
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
1.281
|
|
DPP4
|
dipeptidyl-peptidase 4
|
1.28
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
1.277
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.275
|
|
HPR
|
haptoglobin-related protein
|
1.275
|
|
ETV6
|
ets variant 6
|
1.275
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.267
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
1.254
|
|
FGF16
|
fibroblast growth factor 16
|
1.252
|
|
RANBP2
|
RAN binding protein 2
|
1.249
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
1.248
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
1.241
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.241
|
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
1.23
|
|
THRAP3
|
thyroid hormone receptor associated protein 3
|
1.229
|
|
EXOC1
|
exocyst complex component 1
|
1.223
|
|
FGF18
|
fibroblast growth factor 18
|
1.223
|
|
CD1A
|
CD1a molecule
|
1.221
|
|
FGF17
|
fibroblast growth factor 17
|
1.216
|
|
CFP
|
complement factor properdin
|
1.214
|
|
CD1B
|
CD1b molecule
|
1.214
|
|
FGF22
|
fibroblast growth factor 22
|
1.212
|
|
FGF6
|
fibroblast growth factor 6
|
1.21
|
|
VWF
|
von Willebrand factor
|
1.21
|
|
CCN2
|
cellular communication network factor 2
|
1.209
|
|
FGF3
|
fibroblast growth factor 3
|
1.207
|
|
FGF20
|
fibroblast growth factor 20
|
1.207
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
1.204
|
|
FGF9
|
fibroblast growth factor 9
|
1.203
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
1.203
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.203
|
|
PTH
|
parathyroid hormone
|
1.202
|
|
FGF5
|
fibroblast growth factor 5
|
1.202
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
1.201
|
|
CD1E
|
CD1e molecule
|
1.198
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.198
|
|
FGF4
|
fibroblast growth factor 4
|
1.197
|
|
IFNA4
|
interferon, alpha 4
|
1.195
|
|
FGF10
|
fibroblast growth factor 10
|
1.193
|
|
CTSG
|
cathepsin G
|
1.193
|
|
HP
|
haptoglobin
|
1.191
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.19
|
|
TFCP2
|
transcription factor CP2
|
1.189
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.185
|
|
LPIN2
|
lipin 2
|
1.184
|
|
HTRA1
|
HtrA serine peptidase 1
|
1.182
|
|
THBD
|
thrombomodulin
|
1.182
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.181
|
|
CD1C
|
CD1c molecule
|
1.18
|
|
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
|
1.172
|
|
HAMP
|
hepcidin antimicrobial peptide
|
1.172
|
|
IL3
|
interleukin 3
|
1.172
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
1.17
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
1.168
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.165
|
|
COL1A2
|
collagen, type I, alpha 2
|
1.163
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
1.163
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
1.162
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
1.161
|
|
SIGLEC8
|
sialic acid binding Ig-like lectin 8
|
1.161
|
|
C4B
|
complement component 4B (Chido blood group)
|
1.158
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
1.157
|
|
NF1
|
neurofibromin 1
|
1.157
|
|
IL33
|
interleukin 33
|
1.157
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.156
|
|
MVK
|
mevalonate kinase
|
1.154
|
|
EGF
|
epidermal growth factor
|
1.154
|
|
SDC1
|
syndecan 1
|
1.151
|
|
CD1D
|
CD1d molecule
|
1.148
|
|
PDCD1
|
programmed cell death 1
|
1.147
|
|
CALCOCO2
|
calcium binding and coiled-coil domain 2
|
1.147
|
|
DEFB103A
|
defensin, beta 103A
|
1.141
|
|
RAI1
|
retinoic acid induced 1
|
1.139
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
1.139
|
|
A2M
|
alpha-2-macroglobulin
|
1.139
|
|
BMP2
|
bone morphogenetic protein 2
|
1.139
|
|
GAP43
|
growth associated protein 43
|
1.137
|
|
EXOSC10
|
exosome component 10
|
1.137
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
1.132
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
1.132
|
|
TLR5
|
toll-like receptor 5
|
1.13
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
1.13
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
1.128
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
1.125
|
|
EPHA4
|
EPH receptor A4
|
1.122
|
|
AIF1L
|
allograft inflammatory factor 1-like
|
1.121
|
|
TLR3
|
toll-like receptor 3
|
1.121
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
1.12
|
|
SEC11C
|
SEC11 homolog C (S. cerevisiae)
|
1.118
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
1.118
|
|
CD248
|
CD248 molecule, endosialin
|
1.116
|
|
JAK2
|
Janus kinase 2
|
1.116
|
|
PRG4
|
proteoglycan 4
|
1.116
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
1.115
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
1.111
|
|
CD163
|
CD163 molecule
|
1.106
|
|
VCPIP1
|
valosin containing protein (p97)/p47 complex interacting protein 1
|
1.105
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
1.104
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
1.104
|
|
KRT7
|
keratin 7, type II
|
1.102
|
|
ANKRD54
|
ankyrin repeat domain 54
|
1.1
|
|
ADCY10
|
adenylate cyclase 10 (soluble)
|
1.099
|
|
RPAIN
|
RPA interacting protein
|
1.095
|
|
CD80
|
CD80 molecule
|
1.095
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
1.091
|
|
CD28
|
CD28 molecule
|
1.09
|
|
MMP1
|
matrix metallopeptidase 1
|
1.089
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
1.086
|
|
IFNA2
|
interferon, alpha 2
|
1.082
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
1.081
|
|
JUN
|
jun proto-oncogene
|
1.08
|
|
ESR1
|
estrogen receptor 1
|
1.079
|
|
IL1R1
|
interleukin 1 receptor, type I
|
1.078
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.078
|
|
EPO
|
erythropoietin
|
1.077
|
|
PADI2
|
peptidyl arginine deiminase, type II
|
1.077
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
1.076
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
1.076
|
|
POM121
|
POM121 transmembrane nucleoporin
|
1.073
|
|
CCNB3
|
cyclin B3
|
1.072
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
1.069
|
|
SEC11A
|
SEC11 homolog A (S. cerevisiae)
|
1.069
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
1.069
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
1.068
|
|
GFAP
|
glial fibrillary acidic protein
|
1.067
|
|
TPI1
|
triosephosphate isomerase 1
|
1.066
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
1.064
|
|
NPPB
|
natriuretic peptide B
|
1.063
|
|
CARD14
|
caspase recruitment domain family, member 14
|
1.06
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
1.059
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
1.053
|
|
IFNA17
|
interferon, alpha 17
|
1.05
|
|
CD19
|
CD19 molecule
|
1.05
|
|
IFNA16
|
interferon, alpha 16
|
1.049
|
|
IFNA7
|
interferon, alpha 7
|
1.049
|
|
IFNA14
|
interferon, alpha 14
|
1.049
|
|
IFNA6
|
interferon, alpha 6
|
1.048
|
|
IFNA8
|
interferon, alpha 8
|
1.048
|
|
IFNA10
|
interferon, alpha 10
|
1.048
|
|
IFNA21
|
interferon, alpha 21
|
1.048
|
|
IFNA5
|
interferon, alpha 5
|
1.047
|
|
IFNA13
|
interferon, alpha 13
|
1.045
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
1.043
|
|
COL6A3
|
collagen, type VI, alpha 3
|
1.041
|
|
TRIM21
|
tripartite motif containing 21
|
1.04
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.039
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
1.036
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.033
|
|
MMP9
|
matrix metallopeptidase 9
|
1.032
|
|
IL22
|
interleukin 22
|
1.027
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.025
|
|
NLRC4
|
NLR family, CARD domain containing 4
|
1.025
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
1.024
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.023
|
|
C5AR1
|
complement component 5a receptor 1
|
1.018
|
|
ACR
|
acrosin
|
1.018
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
1.018
|
|
ZNRD2
|
zinc ribbon domain containing 2
|
1.017
|
|
ACVR1
|
activin A receptor, type I
|
1.015
|
|
GCG
|
glucagon
|
1.014
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.014
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
1.014
|
|
SELE
|
selectin E
|
1.013
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.013
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
1.012
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
1.01
|
|
EPX
|
eosinophil peroxidase
|
1.009
|
|
NF2
|
neurofibromin 2 (merlin)
|
1.008
|
|
ACTB
|
actin, beta
|
1.008
|
|
MSRA
|
methionine sulfoxide reductase A
|
1.007
|
|
PF4
|
platelet factor 4
|
1.005
|
|
STX1A
|
syntaxin 1A (brain)
|
1.003
|
|
SAA2
|
serum amyloid A2
|
1.002
|
|
HMGB1
|
high mobility group box 1
|
1.001
|
|
CALCRL
|
calcitonin receptor-like
|
1.001
|
|
CD2
|
CD2 molecule
|
1.0
|
